← Eichor
Condition: Enterobacteriaceae Infections Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Enterobacteriaceae Infections

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administ
Phase 1/Phase 2 · 8 location(s) · SNIPR Biome Aps. · NCT06938867Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care
Phase 4 · 13 location(s) · Uppsala University · NCT07236944Safety, and Efficacy Study of ShigETEC, a Live, Attenuated, Oral Combination Vaccine to Prevent Shigella and ETEC Diseas
Phase 2 · 1 location(s) · Eveliqure Biotechnologies GmbH · NCT07049159Transmission of ESBL-producing Enterobacteriaceae
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT03465683A Study of LBP-EC01 in the Treatment of Acute Uncomplicated UTI Caused by Drug Resistant E. Coli (ELIMINATE Trial)
Phase 2 · 17 location(s) · Locus Biosciences · NCT05488340Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
NA · 26 location(s) · University of Calgary · NCT05219110Predictive Value of a Rectal Swab With Detection of Enterobacteria (ESBL-E), Carbapenemases, and High-level Cephalospori
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07345923Study of the Ecological and Evolutionary Dynamics of Escherichia Coli in the Digestive Commensal Flora
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT05153824Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumo
Phase N/A · 1 location(s) · Fujian Medical University Union Hospital · NCT07086391Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Childre
Phase N/A · 20 location(s) · Centre Hospitalier Intercommunal Creteil · NCT03825874Meropenem vs Azithromycin Efficacy in Case XDR Enteric Fever
Phase 4 · 1 location(s) · Indus Hospital and Health Network · NCT07314281Shigella Sonnei 53G Human Infection Study in Kenyan Adults
Phase 1 · 1 location(s) · University of Oxford · NCT05959616InvaplexAR-Detox and DmLT Adjuvant in the Netherlands and Zambia
Phase 1 · 1 location(s) · Leiden University Medical Center · NCT05961059Study of E. Coli Isolates From Recurrent Urinary Tract Infections
Phase N/A · 1 location(s) · Université Catholique de Louvain · NCT05826067EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Phase 4 · 4 location(s) · National University of Singapore · NCT05979545A Study to Evaluate the Safety, Reactogenicity, and Immune Response of the GSK Vaccines Institute for Global Health (GVG
Phase 1 · 1 location(s) · GlaxoSmithKline · NCT07663032A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal S
Phase 2 · 1 location(s) · GlaxoSmithKline · NCT07286370Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated
NA · 1 location(s) · Hanoi University of Public Health · NCT05871476Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria
Phase 1 · 2 location(s) · Barbara Trautner · NCT06559618FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae
Phase 1/Phase 2 · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT04759001Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
NA · 2 location(s) · Odense University Hospital · NCT04846803Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae I
NA · 15 location(s) · Southeast University, China · NCT06051513Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enter
Phase 4 · 14 location(s) · Rambam Health Care Campus · NCT03671967Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT06910878A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Cl
Phase 1/Phase 2 · 8 location(s) · GlaxoSmithKline · NCT06702449First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Yo
Phase 1 · 1 location(s) · Inventprise Inc. · NCT07205926Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
Phase N/A · 1 location(s) · Children's Hospital of Fudan University · NCT04535661International Surveillance of Antimicrobial Resistance in Cirrhosis-Related Infections
Phase N/A · 1 location(s) · Hospital Italiano de Buenos Aires · NCT06634940NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05017766
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.